Pancreatic ductal adenocarcinoma comprises more than 90% of pancreatic tumors. It is the 10th most common cancer diagnosis in the United States, but represents the fourth most common cause of…
Pancreatic adenocarcinoma is the fourth leading cause of cancer death in the United States, with a 5-year survival rate of 5.6%. One third of pancreatic cancer patients have local or…
Surgical resection remains an important component in the treatment of pancreatic cancer. Unfortunately, only approximately 10% to 20% of patients are eligible for surgical resection at presentation. Many patients with…
Pancreatic adenocarcinoma (PC) is the fourth leading cause of cancer death and is associated with an extremely poor prognosis: The 5-year survival probability is less than 5% for all stages…
According to the American Cancer Society, 43,140 new cases and 36,800 deaths from pancreatic cancer were expected in 2010. The incidence of pancreatic adenocarcinoma in the United States decreased by…
Clinical Overview Each year in the United States, more than 40,000 patients are diagnosed with pancreatic cancer and a nearly equal number will die from their disease. Pancreatic cancer is…
Pancreatic Cancer: Why Consider Screening? Pancreatic cancer remains one of the most deadly diseases, despite significant advances in medicine over the past decade. Pancreatic adenocarcinoma is the fourth leading cause…
In the early part of the 20th century, many research groups were trying to isolate insulin from the other digestive proteins of the pancreas. In 1921, Fredrick Banting and his…
Pancreatic cystic lesions are being detected with increasing frequency, at least partly because of the increased use of cross-sectional imaging for the evaluation of abdominal complaints or screening for other…
Laparoscopic surgery offers several significant advantages over open surgery, including more rapid recovery, lower wound complication rates, shorter hospital stay with its associated cost savings, and avoidance of large, chevron-type…
